Health state utilities for metastatic breast cancer in Taiwan

Background: New developments in medications for metastatic breast cancer (MBC) can be of great benefit to patients, but unfortunately these medicines also increase expenditures. Cost-utility analyses (CUAs) are needed to allocate health resources properly, and health utility values are required to c...

Full description

Bibliographic Details
Main Authors: Tzu-Chun Chou, Shao-Chin Chiang, Yu Ko
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977620300710